相关实验视频

Updated: Jun 1, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

保护作用和Zanthoxylum bungeanum Maxim的潜在机制. 关于动脉样硬化症的

Zongchao Li¹, Ruoxuan Xu¹, Can Li¹

¹School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China.

|January 18, 2025

概括

桑托克西勒姆邦基安姆 (Zanthoxylum bungeanum) 马克西姆 (Maxim) 是一个植物. 骨提取物 (ZBM) 通过改善脂质谱和减少大动脉斑块,有效地治疗小鼠的动脉样硬化. 它通过调节关键代谢途径和通过STAT3和Nrf2/HO-1信号传递抑制血管光滑肌细胞的增殖而起作用.

科学领域:

药理学药理学是指药理学的学科.
代谢学代谢学代谢学
心血管研究研究心血管研究

背景情况:

桑托克西勒姆邦基安姆 (Zanthoxylum bungeanum) 马克西姆 (Maxim) 是一个植物. (ZBM) 具有抗肥胖,抗炎症和心血管方面的益处.
动脉样硬化 (AS) 是一种慢性炎症性疾病,其特征是脂质积累和血管重塑.

研究的目的:

在小鼠模型中研究ZBM对动脉样硬化的治疗作用.
阐明ZBM对AS的作用的潜在机制.

主要方法:

一个体内动脉样硬化模型使用阿波利波蛋白-E缺乏 (ApoE-/-) 的小鼠.
血清代谢分析以确定受调节的代谢途径.
在体外血管光滑肌细胞 (VSMC) 增殖试验.

主要成果:

在AS小鼠中,ZBM的使用显著降低了血脂水平,大动脉脂沉积和内脏加厚.
代谢学揭示了ZBM对TCA循环的调节,类固醇激素生物合成,脂,氧酸和二碳酸,以及糖脂代谢的调节.
通过阻断STAT3酸化和激活Nrf2/HO-1通路,ZBM抑制了VSMC的扩散,导致G0/G1阶段停止和ROS减少.

结论:

ZBM在动脉样硬化中显示出显著的治疗潜力.
通过调节脂质代谢,抑制VSMC增殖,并通过特定的分子途径减少氧化应激,ZBM发挥其保护作用.

关键词:

动脉样硬化是一种动脉样硬化.代谢学代谢学代谢学血管光滑肌肉细胞细胞桑托克西勒姆邦基安姆 (Zanthoxylum bungeanum) 马克西姆 (Maxim) 是一个植物.

更多相关视频

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

Quantification of Atherosclerosis in Mice

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Antihypertensive Drugs: Action of Calcium Channel Blockers

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

Antianginal Drugs: Nitrates and β-Blockers

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....

Inflammation

Inflammation

Antihypertensive Drugs: Vasodilators

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...